Managers / Q2 2025 · view latest →
SYQUANT CAPITAL SAS
CIK 0001766392 · 25 AVENUE KLEBER, PARIS, I0, 75116 · 0033142569307
Summary
Syquant Capital Sas reported $302M in U.S.-listed holdings across 14 positions for Q2 2025.
The portfolio is heavily concentrated: Blueprint Medicine Common Stock alone accounts for 34.2% of reported value.
Compared with Q1 2025, the fund opened 11 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 90.9% · $274M
- Other · 8.5% · $26M
- US DOMESTIC · 0.6% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BluePrint Medicine Common Stock | NEW | +805.6K | 805.6K | +$103M | $103M |
| WBAWALGREENS BOOTS ALLIANCE | NEW | +1.28M | 1.28M | +$15M | $15M |
| Triumph Group Common Stock | NEW | +568.2K | 568.2K | +$15M | $15M |
| JNPJUNIPER NETWORKS | NEW | +302.6K | 302.6K | +$12M | $12M |
| Springworks Therapeutics Inc | NEW | +247.0K | 247.0K | +$12M | $12M |
| SKAASkechers USA Common Stock | NEW | +183.9K | 183.9K | +$12M | $12M |
| DNBDun & Bradstreet Common Stock | NEW | +1.25M | 1.25M | +$11M | $11M |
| AIRBNB INC | NEW | +2.00M | 2.00M | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | BluePrint Medicine Common Stock | COM | 34.24% | $103M | 805.6K |
| 2 | KELKellanovahistory → | COM | 30.16% | $91M | 1.14M |
| 3 | Enstar Group Common Stock | SHS | 8.01% | $24M | 71.8K |
| 4 | WBAWALGREENS BOOTS ALLIANCEhistory → | COM | 4.89% | $15M | 1.28M |
| 5 | Triumph Group Common Stock | COM | 4.85% | $15M | 568.2K |
| 6 | JNPJUNIPER NETWORKShistory → | COM | 4.01% | $12M | 302.6K |
| 7 | Springworks Therapeutics Inc | COM | 3.85% | $12M | 247.0K |
| 8 | SKAASkechers USA Common Stockhistory → | CL A | 3.85% | $12M | 183.9K |
| 9 | DNBDun & Bradstreet Common Stockhistory → | COM | 3.76% | $11M | 1.25M |
| 10 | APPAppLovin Corp | COM CL A | 0.83% | $3M | 7.2K |
| 11 | AIRBNB INC | NOTE 3/1 | 0.64% | $2M | 2.00M |
| 12 | CONConcentra Group Holdings | COMMON STOCK | 0.46% | $1M | 67.8K |
| 13 | Pioneer Acquisition I Corp | UNIT 06/16/2030 | 0.37% | $1M | 110.0K |
| 14 | Wen Acquisition Corp | UNIT 05/16/2030 | 0.09% | $265,000 | 25.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | $447M | 38 | Jul 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q1 2026 | $640M | 40 | Apr 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $817M | 37 | Jan 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $348M | 17 | Oct 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $302M | 14 | Jul 18, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2025 | $141M | 14 | Apr 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $70M | 6 | Jan 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $27M | 5 | Oct 4, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $10M | 5 | Jul 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $64M | 6 | Apr 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $22M | 7 | Jan 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $255M | 9 | Oct 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $138M | 11 | Jul 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $43M | 7 | Apr 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $41M | 14 | Jan 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $165M | 25 | Oct 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $90M | 32 | Jul 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $195M | 35 | Apr 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $262M | 43 | Jan 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $164M | 42 | Oct 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $83M | 41 | Jul 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $386M | 53 | Apr 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $387M | 81 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $196M | 62 | Oct 21, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $215M | 23 | Aug 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $407M | 18 | Apr 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $194M | 16 | Jan 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $365M | 17 | Oct 17, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $312M | 14 | Jul 5, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $258M | 15 | Apr 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $117M | 11 | Feb 4, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.